Jump To Jump To Watch View Summit Archive Top 10 Things to Know About Prostate Cancer Clinical Trials March 3, 2021 Elisabeth Heath, professor of Oncology & Medicine at Karmanos Cancer Institute, and Charles Ryan, professor of Medicine at the University of Minnesota, share important things to know about prostate cancer clinical trials. Clinical trials must reflect the patient community so that new and better treatment options become available. Researchers and trial sponsors can confront health disparities by ensuring clinical trials are diverse, inclusive, and representative of the entire patient population.This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.Watch Summit Session Archives At each ZERO Summit, you'll experience the Bold for Blue Awards, educational sessions, advocacy training, and more. See the video archives to find more of what you can expect to see when you join us at this year’s Summit! View Summit Archive Access to Healthcare Clinical Trials Health Equity Living with Prostate Cancer Treatment Options Videos & Webinars ZERO Prostate Cancer Summit View All Contributors Elisabeth Heath, MD, FACP, Chair, Department of Oncology Dr. Elisabeth Heath is a nationally and internationally recognized expert in genitourinary oncology, serving as the Chair of the Department of Oncology at the Mayo Clinic in Rochester, MN. She specializes in clinical and translational research, focusing on early-phase and genitourinary clinical trials and addressing important health disparities. Her expertise covers a range of genitourinary cancers, including prostate, kidney, and bladder cancer. Charles "Chuck" Ryan, MD, Genitourinary Oncologist Charles J. Ryan, MD, is an internationally recognized genitourinary (GU) oncologist with expertise in the biology and treatment of and supportive care of all men with prostate cancer, seeing patients at Memorial Sloan Kettering Cancer Center in New York. Dr. Ryan earned a BA in Philosophy, magna cum laude, from Marquette University and graduated from the University of Wisconsin Medical School. He trained at the University of Wisconsin Hospital and Clinics, and at Memorial Sloan Kettering Cancer Center. As faculty at the University of California-San Francisco, he was named the Thomas Perkins Distinguished Professor in Cancer Research. He has received research funding from the National Institutes of Health, the Department of Defense Prostate Cancer Research Program, and the Prostate Cancer Foundation. Ryan has published over 200 articles and chapters in the world’s leading medical journals and is the author of the book The Virility Paradox: The Vast Influence of Testosterone on Our Bodies, Minds, and the World We Live In. Dr. Ryan is a past Chair of the National Cancer Institute’s GU Steering Committee’s Prostate Cancer Task Force. From 2018 to 2021 he served as Director of the Division of Hematology, Oncology and Transplantation at the University of Minnesota, where he was the BJ Kennedy Chair in Clinical Oncology. From 2021 to 2024 Ryan served as the CEO of the Prostate Cancer Foundation. He serves on the Scientific Oversight Committee of the Prostate Cancer Clinical Trials Consortium and is a member of the Advanced Prostate Cancer Consensus Conference. Dr. Ryan is a member of ZERO's Medical Advisory Board. Learn more about Charles Shelby Moneer, Vice President, Patient Programs & Education Shelby Moneer was the Vice President of Patient Programs & Education at ZERO Prostate Cancer until April 2025. More for you
Elisabeth Heath, professor of Oncology & Medicine at Karmanos Cancer Institute, and Charles Ryan, professor of Medicine at the University of Minnesota, share important things to know about prostate cancer clinical trials. Clinical trials must reflect the patient community so that new and better treatment options become available. Researchers and trial sponsors can confront health disparities by ensuring clinical trials are diverse, inclusive, and representative of the entire patient population.This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.Watch
Summit Session Archives At each ZERO Summit, you'll experience the Bold for Blue Awards, educational sessions, advocacy training, and more. See the video archives to find more of what you can expect to see when you join us at this year’s Summit! View Summit Archive
Access to Healthcare Clinical Trials Health Equity Living with Prostate Cancer Treatment Options Videos & Webinars ZERO Prostate Cancer Summit View All
